Qube Research & Technologies (QRT)
XBI icon

Qube Research & Technologies (QRT)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-132,600
Closed -$11.9M – 3934
2024
Q4 		$11.9M Hold
132,600
– – 0.02% 989
2024
Q3 		$13.1M Buy
132,600
+8,900
+7% +$874K 0.02% 878
2024
Q2 		$11.5M Sell
123,700
-7,800
-6% -$699K 0.02% 851
2024
Q1 		$12.5M Buy
131,500
+130,900
+21,817% +$12.1M 0.02% 753
2023
Q4 		$53.6K Sell
600
-19,600
-97% -$1.46M ﹤0.01% 3295
2023
Q3 		$1.48M Buy
+20,200
New +$1.61M ﹤0.01% 1546

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Qube Research & Technologies (QRT)'s XBI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 90% in Q2 2026, selling an estimated $23.2M and leaving 19,211 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1900.

Qube Research & Technologies (QRT) first reported a position in XBI in Q1 2020 and has held it in 18 quarters since. The position peaked at $28.6M in Q4 2020. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Qube Research & Technologies (QRT) held 19,211 shares of State Street SPDR S&P Biotech ETF worth $3.04M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 171,506 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $23.2M.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1900 holding.
  • Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 18 quarters since.
  • Qube Research & Technologies (QRT)'s State Street SPDR S&P Biotech ETF position peaked at $28.6M in Q4 2020.
  • 934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.